Assort Health is chasing the silence on the other end of a phone line, the one where patients sit on hold, waiting for someone to schedule an appointment, refill a prescription, or explain a referral. That silence is expensive. It burns hours, patience, and trust. And that’s the inefficiency Co-CEOs Jeffery Liu and Jon Wang set out to kill when they founded Assort Health in January 2023. They didn’t want to build another generic chatbot. They built Assort OS, an agentic AI platform tuned to specialties. It knows the difference between orthopedics and cardiology, pediatrics and dermatology, and handles interactions across voice, SMS, and web with the fluency of a seasoned call center rep, without the dreaded transfer shuffle.
The results speak louder than any hype deck. Assort OS has processed over 42 million patient interactions across hundreds of healthcare organizations, from OrthoIndy to Chesapeake Healthcare to Annapolis Internal Medicine. Providers are reporting satisfaction scores above 94 percent and call resolution rates of 98 percent. Front offices are cutting costs by more than 60 percent and watching patient hold times shrink by nearly 90 percent. This isn’t theory, it’s infrastructure running nationwide, fully integrated with leading EHR and practice management systems, operating at HIPAA-compliant standards, and proving that patient access can finally scale.
That traction just attracted $76 million in fresh capital, a Series B led by Lightspeed Venture Partners with participation from Felicis, First Round Capital, Chemistry, A*, Liquid2 Ventures, and Quiet Capital. It brings total funding to $102 million in less than three years. Galym Imanbayev from Lightspeed Venture Partners is joining the board. Paul Ricci, the founding CEO of Nuance, is advising. Olympic legend Apolo Ohno stepped in as an investor and advisor. This isn’t just capital, it’s strategic weight from people who know how to scale transformative platforms.
The new funds will expand engineering, product, and customer success teams, with a roadmap that adds specialty modules, predictive scheduling to cut no-shows, and AI-driven outreach for preventive care. The vision is a nationwide network of specialty-specific agents that operate with human-level accuracy and machine-level endurance, stripping friction from healthcare logistics so providers can focus on medicine instead of phone trees.
The market is enormous. U.S. adults lose the equivalent of a full workday every month navigating healthcare logistics. That inefficiency translates into billions in wasted time and cost. Assort Health is not nibbling at the edges. It is swallowing inefficiency whole. With Jeffery Liu driving product and Jon Wang driving technology, this isn’t just a play on AI in healthcare. It’s a bet that patients deserve their time back, and providers deserve systems built to keep up with demand. Investors just put nine figures behind that bet.
